论文信息 - Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda. - 字舞流文

Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.

D. Watson-Jones | P. Kaleebu | O. Anzala | G. Omosa-Manyonyi | K. Kasonia | D. Manno | Zacchaeus Anywaine | Auguste Gaddah | Tobias Vudriko | K. Luhn | Cynthia Robinson | B. Lowe | Chelsea McLean | Julie Foster | Brian Greenwood | Philip Ayieko | Y. Njie | Michael Katwere | Edward Man-Lik Choi | Ggayi Abu-Baker Mustapher | Michael Musila Mutua | Irene Ann Mwangi | Kakande Ayoub | Moses Mundia Muriuki | Nicholas Edward Connor | Nambaziira Florence